Cell Bio Human Tech Co.,Ltd (KOSDAQ:318160)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,020.00
-370.00 (-6.86%)
At close: Jun 8, 2026

KOSDAQ:318160 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
18,70315,9173,0994,0524,49513,929
Short-Term Investments
33368411,2079,4332,4007,463
Cash & Short-Term Investments
19,03616,60114,30613,4856,89521,392
Cash Growth
60.48%16.04%6.09%95.59%-67.77%69.12%
Accounts Receivable
9,92410,8564,0144,2413,0723,584
Other Receivables
527.7763.834.9696.4932.52154.82
Receivables
10,46210,9204,0494,3373,1043,739
Inventory
15,09213,8584,5508,2819,1066,254
Prepaid Expenses
213.26756.24459.29308.51281.8555.4
Other Current Assets
1,1261,885628.87506.67548.41630.85
Total Current Assets
45,92944,02123,99226,91819,93632,071
Property, Plant & Equipment
36,52335,49324,56822,76423,15223,904
Long-Term Investments
3,4174,6311,034644.17548.66509.54
Other Intangible Assets
1,6771,4471,2551,282818.32817.77
Long-Term Accounts Receivable
-0----
Long-Term Deferred Tax Assets
-503.92457.97557.14825.57248.83
Other Long-Term Assets
2,8662,3621,5971,030701.66517.12
Total Assets
90,41188,45852,90553,19645,98258,069
Accounts Payable
2,6862,984837.061,048861.031,953
Accrued Expenses
1,4951,782600.95564.82709.24414.39
Short-Term Debt
11,04810,5063,6755,8754,9424,735
Current Portion of Long-Term Debt
575.42604.58----
Current Portion of Leases
199.8209.51217.9529.73220.38233.33
Current Income Taxes Payable
347.32241.2462.79540.81573.61,449
Other Current Liabilities
2,5302,870490499.72441.35833.07
Total Current Liabilities
18,88219,1976,2848,5597,7489,617
Long-Term Debt
8,9558,907---9,421
Long-Term Leases
274.17282.77174.5621.8968.78274.54
Pension & Post-Retirement Benefits
465.37451----
Long-Term Deferred Tax Liabilities
550.37550.37----
Other Long-Term Liabilities
70.0965.8134.8453.0760.3429.76
Total Liabilities
29,19729,4556,4938,6347,87719,342
Common Stock
4,6714,6714,6304,6304,1004,100
Additional Paid-In Capital
27,59227,59223,83523,83518,07718,077
Retained Earnings
28,62326,71617,99513,61621,08631,294
Treasury Stock
-4,074-4,074-2,833-37.25-7,916-7,916
Comprehensive Income & Other
1,7781,3912,3382,072-3,648-17,136
Total Common Equity
58,58956,29645,96544,11631,70028,420
Minority Interest
2,1782,261----
Shareholders' Equity
61,21459,00346,41244,56338,10538,726
Total Liabilities & Equity
90,41188,45852,90553,19645,98258,069
Total Debt
21,05220,5104,0685,9275,23214,663
Net Cash (Debt)
-2,017-3,90910,2387,5581,6636,728
Net Cash Growth
--35.46%354.48%-75.28%-43.71%
Net Cash Per Share
-239.52-476.291147.60894.55237.54852.31
Filing Date Shares Outstanding
8.758.388.549.2677
Total Common Shares Outstanding
8.758.388.549.2677
Working Capital
27,04724,82317,70918,35912,18722,454
Book Value Per Share
6696.876721.255383.594765.584527.974059.42
Tangible Book Value
56,91254,84944,71042,83430,88227,602
Tangible Book Value Per Share
6505.236548.535236.554627.084411.093942.62
Land
-6,7572,3602,3602,3602,360
Buildings
-11,5958,9868,4428,4598,282
Machinery
-15,82311,56510,28710,74210,622
Construction In Progress
-234.69766.68128.0730.27310.99